Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2017-07-04 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
第四届董事会第二次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Guangzhou Yangpu Medical Technology Co., Ltd. It details adjustments to the non-public issuance of A shares, including pricing and lock-up period changes. The document includes voting results and references to regulatory approvals and disclosures on official websites. It does not contain financial statements or detailed financial data but rather decisions and approvals related to capital raising activities. Therefore, it is an update on financing activities and capital structure changes, fitting the Capital/Financing Update (CAP) category. The document length is 2330 characters, which is consistent with an announcement rather than a full report.
2017-07-04 Chinese
独立董事关于调整非公开发行股票方案相关事项的事前认可意见
Capital/Financing Update Classification · 95% confidence The document is a formal opinion from independent directors regarding the adjustment of a non-public stock issuance plan. It references relevant laws and regulations and concludes with the directors' approval to submit the proposal to the board. The content focuses on governance and compliance related to a capital raising activity but does not contain financial statements or detailed financial data. It is not a full report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. The document is best classified as a Capital/Financing Update (CAP) because it pertains to changes in a financing plan (non-public stock issuance). The document length is short and specific to the financing plan adjustment, fitting the CAP category rather than Regulatory Filings or Report Publication Announcement.
2017-07-04 Chinese
关于长安睿享2号分级资产管理计划优先级份额委托人变更的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a change in the trustee of a priority share class within a structured asset management plan related to the company's controlling shareholder's stock holdings. It discusses shareholding details, fund management, and confirms no impact on control or governance. It is not a full financial report, earnings release, or management discussion. It is not a voting result or AGM material. The content fits best with a Major Shareholding Notification (MRQ) as it involves changes in significant share ownership arrangements and related disclosures.
2017-06-30 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the progress of a major asset restructuring and the related trading suspension (stock halt). It details the timeline of suspension notices, ongoing due diligence, and the expected continuation of the trading halt. The document does not contain financial statements or detailed financial analysis but is a regulatory update on the status of a significant corporate event (major asset restructuring). It is not a full report but a progress announcement related to a capital restructuring event. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short (1115 characters), and it is not merely announcing the publication of a report but providing substantive update information on the restructuring progress and trading suspension.
2017-06-28 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a regulatory authority (Guangdong Food and Drug Administration). It describes the product details and the impact on the company's business but does not contain financial data, earnings, or report content. It is a regulatory announcement about a certification or approval, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-06-26 Chinese
关于公司5%以上股东股份质押延期购回的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the extension of the repurchase period for pledged shares held by a shareholder owning more than 5% of the company's stock. It details the shareholder's pledge transactions, including dates, amounts, and pledgees. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, as it concerns significant share ownership and pledge status updates.
2017-06-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.